---
category: news
title: "This Artificial Intelligence Biotech Stock Is Crushing the Market, but Is It a Buy?"
excerpt: "Schr√∂dinger (NASDAQ: SDGR) stock is going bonkers, gaining 191% this year so far thanks to snappy top-line growth and the hype surrounding artificial intelligence (AI), which it uses in its software platform for discovering leads for biopharma drug development."
publishedDateTime: 2023-07-17T14:15:00Z
originalUrl: "https://www.nasdaq.com/articles/this-artificial-intelligence-biotech-stock-is-crushing-the-market-but-is-it-a-buy"
webUrl: "https://www.nasdaq.com/articles/this-artificial-intelligence-biotech-stock-is-crushing-the-market-but-is-it-a-buy"
type: article
quality: 43
heat: 43
published: false

provider:
  name: Nasdaq
  domain: nasdaq.com

topics:
  - AI in Healthcare
  - AI

secured: "dpxUfX3++z5a8t2GR2QAEu/weAWL7SeFQcxU39Ds7aqOnk9ROUx3tTyGC6IViaWUWYHBcX2AO5DrMK3FjypUQwETkCTX3G9EBuTuYQY45R/SA3xOW1o8uRi8gieGpL9eZz4eeI5+rpYWQLp/WuCKGF/OUd9dFXeKvT7T9rSf1r/t00L9oZH8qE7lTamJWI0TwnrHYrJoFFcAJz6Po8tXNCyo6/P8/L9dF91IkrbVSS9gVEf1bwiCQuUju9I2Rd38s8Fo0MR8bqKJN7d3XbWQ/cyx4+QIMIj/IdKIYHVrR8SQCweps+Vk77WSbJuQuV6t5LZaONRALJUVtWpxrQHmO+1Ro4PGtNVh1bx9/s0auZY=;Me8RPz0q9zZITjIOXa5WuA=="
---

